Vitalstoffe 4/2021

Pflanzenextrakte
Referenzen:
(1) SCENIHR (Scientific Committee on
Emerging and Newly Identified Health
Risks). Health Effects of Artificial Light.
2012. 1–118 p.
(2) Kemin Technical Literature. FloraGLO
® : Clinically Proven and Most
Researched Lutein Brand Worldwide
SUMMARY OF HUMAN CLINICAL
TRIALS. KHTL-017-083
(3) KeminTechnical Literature. Prevalence
of lutein versus lutein esters in
human diets based on USDA-NNCA
Carotenoid database for foods, 1998
and USDA statistic reports 1999.
KHTL-017-80325.
(4) Stahl W. Macular carotenoids:
lutein and zeaxanthin. Dev Ophthalmol.
2005;38:70–88.
(5) Bernstein PS, Khachik F, Carvalho
LS, Muir GJ, Zhao DY, Katz NB.
Identification and quantitation of
carotenoids and their metabolites in the
tissues of the human eye. Exp Eye Res.
2001;72(3):215–23.
(6) Khachik F, Spangler CJ, Smith
JC, Canfield LM, Steck A, Pfander
H. Identification, Quantification, and
Relative Concentrations of Carotenoids
and Their Metabolites in Human Milk
and Serum. Anal Chem. 1997 May
15;69(10):1873–81.
(7) Sherry CL, Oliver JS, Renzi LM,
Marriage BJ. Lutein Supplementation
Increases Breast Milk and Plasma Lutein
Concentrations in Lactating Women
and Infant Plasma Concentrations but
Does Not Affect Other Carotenoids. J
Nutr. 2014;144(8):1256–63.
(8) Hata TR, Scholz TA, Ermakov I
V., McClane RW, Khachik F, Gellermann
W, et al. Non-invasive Raman
spectroscopic detection of carotenoids
in human skin. J Invest Dermatol.
2000;115(3):441–8.
(9) Wooten BR, Hammond BR. Macular
pigment: Influences on visual acuity
and visibility. Prog Retin Eye Res.
2002;21(2):225–40.
(10) Britton G. Structure and properties
of carotenoids in relation to function.
FASEB J. 1995;9(15):1551–8.
11) Bernstein PS, Delori FC, Richer S,
van Kuijk FJM, Wenzel AJ. The value
of measurement of macular carotenoid
pigment optical densities and distributions
in age-related macular degeneration
and other retinal disorders. Vision
Res. 2010;50(7):716–28.
(12) Bian Q, Qin T, Ren Z, Wu D, Shang
F. Lutein or zeaxanthin supplementation
suppresses inflammatory responses
in retinal pigment epithelial cells and
macrophages. Adv Exp Med Biol.
2012;723:43–50.
(13) Sujak A, Gabrielska J, Grudziński
W, Borc R, Mazurek P, Gruszecki WI.
Lutein and zeaxanthin as protectors
of lipid membranes against oxidative
damage: The structural aspects. Arch
Biochem Biophys. 1999;371(2):301–7.
(14) Bovier ER, Renzi LM, Hammond
BR. A double-blind, placebo-controlled
study on the effects of lutein and zeaxanthin
on neural processing speed and
efficiency. PLoS One. 2014;9(9):1–6.
(15) Bovier ER, Hammond BR. A
randomized placebo-controlled study
on the effects of lutein and zeaxanthin
on visual processing speed in young
healthy subjects. Arch Biochem Biophys.
2015;572:54–7.
(16) Renzi LM, Hammond BR. The
relation between the macular carotenoids,
lutein and zeaxanthin, and
temporal vision. Ophthalmic Physiol
Opt. 2010;30(4):351–7.
(17) Hammond BR, Fletcher LM, Elliott
JG. Glare disability, photostress recovery,
and chromatic contrast: Relation to
macular pigment and serum lutein and
zeaxanthin. Investig Ophthalmol Vis Sci.
2013;
(18) Stringham JM, Hammond BR.
The glare hypothesis of macular
pigment function. Optom Vis Sci.
2007;84(9):859–64.
(19) Stringham JM, Garcia P V., Smith
PA, McLin LN, Foutch BK. Macular
pigment and visual performance in
glare: Benefits for photostress recovery,
disability glare, and visual discomfort.
Investig Ophthalmol Vis Sci.
2011;52(10):7406–15.
(20) Stringham JM, Hammond BR. Macular
pigment and visual performance
under glare conditions (Optometry
and Vision Science (2008) 85 (82-88)).
Optom Vis Sci. 2008;85(4):285.
(21) Loughman J, Nolan JM, Howard
AN, Connolly E, Meagher K, Beatty
S. The impact of macular pigment
augmentation on visual performance
using different carotenoid formulations.
Investig Ophthalmol Vis Sci.
2012;53(12):7871–80.
(22) Kimlin JA, Black AA, Wood JM.
Nighttime driving in older adults:
Effects of glare and association with
mesopic visual function. Investig Ophthalmol
Vis Sci. 2017;58(5):2796–803.
(23) Hammond BR, Fletcher LM, Roos
F, Wittwer J, Schalch W. A double-blind,
placebo-controlled study on the effects
of lutein and zeaxanthin on photostress
recovery, glare disability, and chromatic
contrast. Investig Ophthalmol Vis Sci.
2014;55(12):8583–9.
(24) Roberts R. US Patent 9,226,940
B2. Method of Treating Ocular Disorders.
2016.
Autorin:
Samanta Maci, Biologin, MSc
Sr. Commercial and Technical Manager
Kemin Human Nutrition and Health
samanta.maci@kemin.com
Weitere Informationen auf:
www.kemin.com/health
November 2021
51